Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD

Methylphenidate (MPH) is the treatment of first choice for developmental ADHD. To date, no reliable method to predict how patients will respond to MPH exists and conflicting results are reported on clinical characteristics of responders. The present study aims to give a more precise characterization...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Aiello, Barbara, Di Vara, Silvia, De Rossi, Pietro, Pretelli, Italo, Vicari, Stefano, Menghini, Deny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834961/
https://www.ncbi.nlm.nih.gov/pubmed/35162663
http://dx.doi.org/10.3390/ijerph19031640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834961/
https://www.ncbi.nlm.nih.gov/pubmed/35162663
http://dx.doi.org/10.3390/ijerph19031640

Ejemplares similares